4 ms·
It's unusual but not unheard of for trials to be stopped ahead of schedule because of this - the treatment is so clearly and substantially beneficial it's consi
by brianmcc 5y ago
It's unusual but not unheard of for trials to be stopped ahead of schedule because of this - the treatment is so clearly and substantially beneficial it's considered unethical to continue depriving the control group of the treatment.
When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches:
https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.111.965707 https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.111...
- tinus_hn 5y agoIn this case the alternative to the trial would be the ‘dangerous’ option of no treatment. So that doesn’t really apply here.
- putnambr 5y agoHow does it not apply here? Are you saying that no treatment (right now there are no standards of care for COVID-19) is not dangerous? If I recall correctly, that option is leading to people dying.
- tinus_hn 5y agoRead again. > In this case the alternative to the trial would be the […] option of no treatment So the alternative is what we do now, which indeed is the ‘dangerous’ option.